Graham Capital Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-913
Closed -$262K – 1438
2025
Q3
$262K Buy
+913
New +$245K ﹤0.01% 918
2024
Q2
– Sell
-16,901
Closed -$3.69M – 1216
2024
Q1
$3.69M Buy
+16,901
New +$3.72M 0.07% 153
2023
Q2
– Sell
-3,310
Closed -$652K – 1148
2023
Q1
$652K Buy
+3,310
New +$681K 0.02% 662
2022
Q4
– Sell
-1,297
Closed -$228K – 1193
2022
Q3
$228K Buy
+1,297
New +$266K 0.01% 967

Other funds holding LH

Graham Capital Management's LH Position: Q4 2025 in Review

Graham Capital Management sold out of Labcorp (LH) in Q4 2025, closing a stake of 913 shares — an estimated $262K sold.

Graham Capital Management first reported a position in LH in Q3 2022 and held it in 4 quarters. The position peaked at $3.69M in Q1 2024. 1,029 funds tracked by Wall St. Rank hold LH as of Q4 2025.

  • Graham Capital Management reported no remaining Labcorp position as of Q4 2025 after selling out during the quarter.
  • Graham Capital Management sold 913 Labcorp shares in Q4 2025, an estimated $262K.
  • Graham Capital Management first reported a position in Labcorp in Q3 2022 and held it in 4 quarters.
  • Graham Capital Management's Labcorp position peaked at $3.69M in Q1 2024.
  • 1,029 funds tracked by Wall St. Rank held Labcorp as of Q4 2025.

Based on Graham Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.